tiprankstipranks
BriaCell Therapeutics Corp (DE:8BT)
FRANKFURT:8BT
Germany Market

BriaCell Therapeutics (8BT) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
BriaCell Therapeutics Corp’s (8BT) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting BriaCell Therapeutics Corp is a Sell.
BriaCell Therapeutics Corp’s (8BT) 20-Day exponential moving average is 2.95, while BriaCell Therapeutics Corp’s (8BT) share price is €6.4, making it a Buy.
BriaCell Therapeutics Corp’s (8BT) 50-Day exponential moving average is 2.92, while BriaCell Therapeutics Corp’s (8BT) share price is €6.4, making it a Buy.

BriaCell Therapeutics (8BT) Pivot Points

Jul 22, 2026, 09:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.22
3.22
3.22
3.22
3.22
3.22
3.22
Fibonacci
3.22
3.22
3.22
3.22
3.22
3.22
3.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BriaCell Therapeutics (8BT) Moving Averages

Jul 22, 2026, 09:29 PM
Period
Simple
Exponential
MA5
3.17Sell
3.15Sell
MA10
3.13Sell
3.09Sell
MA20
2.89Buy
2.95Buy
MA50
2.78Buy
2.92Buy
MA100
3.09Sell
3.33Sell
MA200
5.08Sell
4.74Sell
BriaCell Therapeutics Corp’s (8BT) 10-Day exponential moving average is 3.09, while BriaCell Therapeutics Corp’s (8BT) share price is €6.4, making it a Sell.
BriaCell Therapeutics Corp’s (8BT) 100-Day exponential moving average is 3.33, while BriaCell Therapeutics Corp’s (8BT) share price is €6.4, making it a Sell.
BriaCell Therapeutics Corp’s (8BT) stock price is €6.4 and BriaCell Therapeutics Corp’s (8BT) 50-day simple moving average is 2.78, creating a Buy signal.
BriaCell Therapeutics Corp’s (8BT) stock price is €6.4 and BriaCell Therapeutics Corp’s (8BT) 100-day simple moving average is 3.09, creating a Sell signal.
BriaCell Therapeutics Corp’s (8BT) stock price is €6.4 and BriaCell Therapeutics Corp’s (8BT) 200-day simple moving average is 5.08, creating a Sell signal.

BriaCell Therapeutics (8BT) Technical Indicators

Jul 22, 2026, 09:29 PM
Name
Value
Implied Action
RSI (14)
53.79
Neutral
STOCH (9,6)
69.70
Neutral
STOCHRSI (14)
80.15
Sell
MACD (12,26)
0.14
Sell
ADX (14)
28.55
Neutral
Williams %R
-43.75
Buy
CCI (14)
48.53
Neutral
ATR (14)
0.16
-
Ultimate Oscillator
50.64
Neutral
ROC
6.99
Buy
BriaCell Therapeutics Corp’s (8BT) Relative Strength Index (RSI) is 53.79, creating a Neutral signal.
BriaCell Therapeutics Corp’s (8BT) Trend Strength Indicator (ADX) is 28.55, creating a Neutral signal.
BriaCell Therapeutics Corp’s (8BT) Commodity Channel Index (CCI) is 48.53, creating a Neutral signal.
BriaCell Therapeutics Corp’s (8BT) Price Rate of Change (ROC) is 6.99, creating a Buy signal.

FAQ

Is 8BT a Buy, Hold, or Sell?
Based on 8BT’s technical indicators, 8BT is a Sell.
    What is 8BT’s RSI (14)?
    8BT’s RSI (14) is 53.79, which suggests 8BT is a Neutral.
      What is 8BT’s MACD?
      8BT’s MACD is 0.14, which suggests 8BT is a Sell.
        What is 8BT’s 5-day moving average?
        8BT’s 5-day moving average is 3.17, which suggests 8BT is a Sell.
          What is 8BT’s 20-day moving average?
          8BT 20-day moving average is 2.89, which suggests 8BT is a Buy.
            What is 8BT’s 50-day moving average?
            8BT’s 50-day moving average is 2.78, which suggests 8BT is a Buy.
              What is 8BT’s 200-day moving average?
              8BT’s 200-day moving average is 5.08, which suggests 8BT is a Sell.
                What is 8BT’s Williams % R (14)?
                8BT’s Williams % R (14) is -43.75, which suggests 8BT is a Buy.
                  What is 8BT’s CCI (14)?
                  8BT’s CCI (14) is 48.53, which suggests 8BT is a Neutral.
                    What is the share price of BriaCell Therapeutics Corp?